These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29514266)

  • 1. SCH79797 improves outcomes in experimental bacterial pneumonia by boosting neutrophil killing and direct antibiotic activity.
    Gupta N; Liu R; Shin S; Sinha R; Pogliano J; Pogliano K; Griffin JH; Nizet V; Corriden R
    J Antimicrob Chemother; 2018 Jun; 73(6):1586-1594. PubMed ID: 29514266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease-activated receptor 1-selective antagonist SCH79797 inhibits cell proliferation and induces apoptosis by a protease-activated receptor 1-independent mechanism.
    Di Serio C; Pellerito S; Duarte M; Massi D; Naldini A; Cirino G; Prudovsky I; Santucci M; Geppetti P; Marchionni N; Masotti G; Tarantini F
    Basic Clin Pharmacol Toxicol; 2007 Jul; 101(1):63-9. PubMed ID: 17577318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMX Represses Thrombin-PAR1-Mediated Endothelial Permeability and Vascular Leakage During Early Sepsis.
    Li Z; Yin M; Zhang H; Ni W; Pierce RW; Zhou HJ; Min W
    Circ Res; 2020 Feb; 126(4):471-485. PubMed ID: 31910739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of proinflammatory cytokines by SCH79797, a selective protease-activated receptor 1 antagonist, protects rat kidney against ischemia-reperfusion injury.
    El Eter EA; Aldrees A
    Shock; 2012 Jun; 37(6):639-44. PubMed ID: 22592635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAR1, a therapeutic target for remote lung injury associated with hind limb ischemia/reperfusion: ERK5/KLF2-dependent lung capillary barrier preservation.
    Kamel NM; El-Tanbouly DM; Abdallah DM; Sayed HM
    Chem Biol Interact; 2022 Feb; 354():109809. PubMed ID: 35031271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease-activated receptor 1 inhibition by SCH79797 attenuates left ventricular remodeling and profibrotic activities of cardiac fibroblasts.
    Sonin DL; Wakatsuki T; Routhu KV; Harmann LM; Petersen M; Meyer J; Strande JL
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):460-75. PubMed ID: 23598708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of PAR-1 Signaling Attenuates Cardiac Hypertrophy and Fibrosis in Renin-Overexpressing Hypertensive Mice.
    Yokono Y; Hanada K; Narita M; Tatara Y; Kawamura Y; Miura N; Kitayama K; Nakata M; Nozaka M; Kato T; Kudo N; Tsushima M; Toyama Y; Itoh K; Tomita H
    J Am Heart Assoc; 2020 Jun; 9(12):e015616. PubMed ID: 32495720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of spinal thrombin through protease-activated receptor 1 in hyperalgesia after neural injury.
    J Neurosurg Spine; 2017 Apr; 26(4):532-541. PubMed ID: 28059686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of SCH79797 in maintaining vascular integrity in rat model of subarachnoid hemorrhage.
    Yan J; Manaenko A; Chen S; Klebe D; Ma Q; Caner B; Fujii M; Zhou C; Zhang JH
    Stroke; 2013 May; 44(5):1410-7. PubMed ID: 23539525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of protease-activated receptor 1 in status epilepticus-induced epileptogenesis.
    Isaev D; Lushnikova I; Lunko O; Zapukhliak O; Maximyuk O; Romanov A; Skibo GG; Tian C; Holmes GL; Isaeva E
    Neurobiol Dis; 2015 Jun; 78():68-76. PubMed ID: 25843668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PAR1 antagonist, SCH79797, alters platelet morphology and function independently of PARs.
    Lee H; Hamilton JR
    Thromb Haemost; 2013 Jan; 109(1):164-7. PubMed ID: 23093354
    [No Abstract]   [Full Text] [Related]  

  • 12. PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact.
    Judge HM; Jennings LK; Moliterno DJ; Hord E; Ecob R; Tricoci P; Rorick T; Kotha J; Storey RF
    Platelets; 2015; 26(3):236-42. PubMed ID: 24750101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions.
    Hosokawa K; Ohnishi T; Miura N; Sameshima H; Koide T; Tanaka KA; Maruyama I
    Thromb Res; 2014 Jan; 133(1):66-72. PubMed ID: 24268424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAR-1 antagonist SCH79797 ameliorates apoptosis following surgical brain injury through inhibition of ASK1-JNK in rats.
    Manaenko A; Sun X; Kim CH; Yan J; Ma Q; Zhang JH
    Neurobiol Dis; 2013 Feb; 50():13-20. PubMed ID: 23000356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin induces cyclooxygenase-2 expression and prostaglandin E2 release via PAR1 activation and ERK1/2- and p38 MAPK-dependent pathway in murine macrophages.
    Lo HM; Chen CL; Tsai YJ; Wu PH; Wu WB
    J Cell Biochem; 2009 Dec; 108(5):1143-52. PubMed ID: 19739103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 deficiency leads to enhanced neutrophil migration and lung injury in Escherichia coli pneumonia in mice.
    Wang Q; Teder P; Judd NP; Noble PW; Doerschuk CM
    Am J Pathol; 2002 Dec; 161(6):2219-28. PubMed ID: 12466136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin contributes to the injury development and neurological deficit after acute subdural hemorrhage in rats only in collaboration with additional blood-derived factors.
    Krämer TJ; Sakas W; Jussen D; Krenzlin H; Kempski O; Alessandri B
    BMC Neurosci; 2018 Dec; 19(1):81. PubMed ID: 30591020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCH 79797, a selective PAR1 antagonist, protects against ischemia/reperfusion-induced arrhythmias in the rat hearts.
    Mohamed OY; Al-Masri AA; El Eter EA; Lateef R
    Eur Rev Med Pharmacol Sci; 2016 Nov; 20(22):4796-4800. PubMed ID: 27906419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta1 increases microbial clearance but worsens lung injury during Escherichia coli pneumonia in rats.
    Cui X; Zeni F; Vodovitz Y; Correa-de-Araujo R; Quezado M; Roberts A; Wahl S; Danner RL; Banks SM; Gerstenberger E; Fitz Y; Natanson C; Eichacker PQ
    Cytokine; 2003 Nov; 24(4):115-27. PubMed ID: 14572790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherent-invasive Escherichia coli Exacerbates Antibiotic-associated Intestinal Dysbiosis and Neutrophil Extracellular Trap Activation.
    Vong L; Yeung CW; Pinnell LJ; Sherman PM
    Inflamm Bowel Dis; 2016 Jan; 22(1):42-54. PubMed ID: 26398709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.